JP Morgan 2022
JP Morgan 2022
For the third consecutive year, AusBiotech is beginning the year with a bang!
On behalf of the sector, this year during JP Morgan week AusBiotech is hosting a virtual Australian Showcase: highlighting the compelling life sciences opportunities in medical innovation and clinical trials, and we’re connecting our thriving and mature biotech companies with international capital.
AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences community, and its international missions illustrate the globally-recognised strength of the Australian life sciences sector, and connects companies with international capital markets to empower them to be competitive on a global scale. This is an important opportunity for Australian companies engaging with global life science decision-makers, and for collaboration, partnership, and investment discussions.
Investors and partners: take a glimpse into Australia's innovative biotech industry
AusBiotech is proud to profile 15 home-grown companies and demonstrate the breadth of investment and partnering opportunities available across Australia.
These engaging presentations are targeted to those in venture capital, private equity, HNW individuals, research analysts and brokers, as well as industry executives from major global pharmaceutical companies.
Australia’s biotechnology industry presents a compelling opportunity.
International clinical development companies: Learn about Australia's clinical trial and medical innovation advantages
Working in Australia offers a compelling opportunity for clinical trials, with robust regulation, strong networks and excellent engagement with clinicians/researchers, an R&D Tax Incentive, and access to established and proven pathways of obtaining high quality clinical data recognised by US and European regulators, and other global institutions.
This showcase will highlight how Australia’s clinical trials: are a cornerstone for medical innovation; actively supports innovative local companies with their R&D; and how, together with the unique initiatives offered by three key States, offer an attractive environment for companies from around the world to develop their intellectual property in Australia.
